Guaifenesin PCD Pharma Franchise Company
Cafoli Lifecare is a WHO-GMP certified pharmaceutical company offering 21 Guaifenesin formulations for PCD pharma franchise, distributors and monopoly marketing partners across India. The range covers expectorant syrups, paediatric drops and tablets, often in combination cough-and-cold presentations.
What is Guaifenesin?
Guaifenesin is an expectorant that reduces the viscosity of bronchial secretions, making a productive cough more effective at clearing mucus and chest congestion. It is widely used in cough-and-cold preparations, frequently combined with antitussives, decongestants or antihistamines. Reference: PubChem.
Available Guaifenesin Formulations
Cafoli Lifecare's Guaifenesin portfolio is available as Drop, Syrup and Tablet, letting franchise partners serve paediatric and adult cough demand from a single supplier.
Therapeutic Applications
Guaifenesin preparations are used for productive (chesty) cough, bronchitis and upper-respiratory congestion. They are prescribed by general physicians, paediatricians, pulmonologists and ENT specialists, and form the backbone of most combination cough syrups.
Why Guaifenesin is a High-Potential Molecule for Distributors
Cough-and-cold is one of the largest and most seasonal OTC-plus-prescription segments in India. Guaifenesin's role in nearly every combination cough syrup gives it broad, repeatable demand, and its syrup and drop formats support strong paediatric and family-practice sales for franchise partners.
Why Choose Cafoli Lifecare
Cafoli Lifecare offers monopoly (district-wise) distribution rights, WHO-GMP and DCGI-approved manufacturing, attractive net rates, complete promotional inputs (visual aids, MR bags, product cards) and prompt dispatch — trusted by 1000+ franchise partners across India.
References
- PubChem – Guaifenesin
- MedlinePlus – Guaifenesin
Our formulations of Guaifenesin find application in many critical therapeutic areas. Its therapeutic spectrum includes, but is not limited to: